| Market Capitalization (Millions $) |
380 |
| Shares
Outstanding (Millions) |
104 |
| Employees |
534 |
| Revenues (TTM) (Millions $) |
247 |
| Net Income (TTM) (Millions $) |
-2 |
| Cash Flow (TTM) (Millions $) |
-122 |
| Capital Exp. (TTM) (Millions $) |
4 |
Business Description
Revance Therapeutics Inc is a biotechnology company that specializes in developing and commercializing innovative therapies for cosmetic and therapeutic applications. The company was founded in 1999 and is headquartered in Newark, California.
Revance Therapeutics Inc's main focus is on developing a new generation of neuromodulators that has the potential to revolutionize the field of aesthetics and therapeutics. Neuromodulators are medications that can selectively disrupt nerve transmission, leading to muscle relaxation and paralysis. These medications are commonly used for cosmetic treatments such as smoothing out wrinkles and fine lines, but they can also treat various medical conditions such as dystonia, spasticity, and migraines.
The core technology platform of Revance Therapeutics Inc is its proprietary peptide technology called RT00 RT002 is a novel form of botulinum toxin type A that has been formulated to have a longer-lasting effect and a more targeted delivery. It has been shown to have a high degree of efficacy, durability, and safety, making it a promising alternative to older neuromodulators. Revance Therapeutics Inc has filed for regulatory approval in the United States, Europe, and Canada for RT002 as both a cosmetic therapy and a therapeutic agent.
In addition to its lead product, Revance Therapeutics Inc is also developing other products in its pipeline, including a topical formulation of RT002 for at-home use, and a dermal filler product that uses a novel approach to achieve long-lasting effects.
The company's management team includes seasoned executives and scientists with extensive experience in the biotechnology industry. Its board of directors includes experts in regulatory affairs, finance, and business development.
Revance Therapeutics Inc is at the forefront of innovation in the field of neuromodulators, and its commitment to bringing safe and effective treatments to patients and consumers has earned it a reputation as a rising star in the biotechnology industry.
Company Address: 1222 Demonbreun Street, Suite 2000 Nashville 37203 TN
Company Phone Number: 724-7755 Stock Exchange / Ticker: NASDAQ RVNC
|
0.000%
1.75%